Elizabeth Inch, a 40 year old female from the Internet asks on November 2, 1999,Could Dr. Michael Smith's discovery of site-directed mutagenesis be of benefit specifically to patients with cancer or Alzheimer's disease? If so, how?
viewed 14733 times
The short answer is yes, and the second part is we don't know. If it was discovered that there are genetic reasons for Alzheimer's or certain cancers, then it might be possible to change the genes of an individual using site-based mutagenesis, maybe while the person was still an egg or an embryo, so that these genes are not expressed later in life. However, this is just science fiction at present.
Note: All submissions are moderated prior to posting.
If you found this answer useful, please consider making a small donation to science.ca.